MDI Guidance Dose Content Uniformity Specs Are Too Restrictive, Firms Say
Executive Summary
Acceptance criteria for dose content uniformity in FDA's metered-dose inhaler guidance is too restrictive, Glaxo Wellcome and other MDI manufacturers asserted in comments to the agency.